admin 
Hendra Lukman 
George Ongkojoyo 
Budi Oetomo Narendra A Groundbreaking Technique Reveals Immune Cell Count in Blood as a Powerful Predictor of Cancer Survival
Lina carolina A revolutionary new method developed by researchers at University College London (UCL) and the Francis...
Scientists Develop Novel Antibody Targeting SFRP2 to Combat Triple Negative Breast Cancer and Overcome Treatment Resistance
Gabriel Paijo Triple-negative breast cancer (TNBC) remains one of the most formidable challenges in modern oncology, characterized...
Personalized Vitamin D3 Therapy Halves Recurrence of Heart Attacks in Landmark Study
A groundbreaking study conducted by Intermountain Health in Salt Lake City has revealed that a...
Mitochondrial Transplantation Enhances Chemotherapy Efficacy and Restores Immune Function in Advanced Non-Small Cell Lung Cancer Treatment
The global oncology community has long grappled with the inherent limitations of conventional chemotherapy, particularly...
Comprehensive Management and Advocacy Strategies for Families Navigating Pediatric Oncology Diagnoses
The notification of a pediatric cancer diagnosis represents a transformative crisis for family units, requiring...
Celebrating the Remarkable Career of Dr. Christopher Moertel
Dr. Christopher Moertel, the Kenneth and Betty Jayne Dahlberg Professor of Pediatrics at the University...
The Heart of the Trail: How CureSearch Ultimate Hike Mobilizes Communities to Fund Critical Pediatric Cancer Research
The CureSearch Ultimate Hike represents a convergence of physical endurance, emotional resilience, and philanthropic dedication,...
Disrupting the Status Quo: How Women are Carrying the Future of Immunotherapy Forward
The eight women highlighted by CRI represent a powerful continuum of courage, intellectual curiosity, and...
A Groundbreaking Liquid Biopsy Promises Earlier Detection and Improved Outcomes for HPV-Associated Head and Neck Cancers
Nana O A revolutionary new liquid biopsy blood test developed by Mass General Brigham researchers holds the...
Exploring a Novel Alternative for Breast Cancer Prevention Amidst Tamoxifen’s Challenges for High-Risk Women
Billy Candra Approximately 25% of women in the United States between the ages of 45 and 60...
